A detailed history of Macquarie Group LTD transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Macquarie Group LTD holds 3,497 shares of ACRS stock, worth $7,308. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,497
Holding current value
$7,308
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$1.01 - $1.36 $3,531 - $4,755
3,497 New
3,497 $3,000
Q3 2021

Nov 12, 2021

BUY
$13.38 - $18.8 $20,979 - $29,478
1,568 New
1,568 $28,000

Others Institutions Holding ACRS

About Aclaris Therapeutics, Inc.


  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $139M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.